FI931822A0 - Foerestaellning av infektioner - Google Patents

Foerestaellning av infektioner

Info

Publication number
FI931822A0
FI931822A0 FI931822A FI931822A FI931822A0 FI 931822 A0 FI931822 A0 FI 931822A0 FI 931822 A FI931822 A FI 931822A FI 931822 A FI931822 A FI 931822A FI 931822 A0 FI931822 A0 FI 931822A0
Authority
FI
Finland
Prior art keywords
pct
date
infection
sec
adjustment
Prior art date
Application number
FI931822A
Other languages
English (en)
Other versions
FI931822A (fi
FI119972B (fi
Inventor
Kishor Khandubhai Solanki
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Publication of FI931822A0 publication Critical patent/FI931822A0/fi
Publication of FI931822A publication Critical patent/FI931822A/fi
Application granted granted Critical
Publication of FI119972B publication Critical patent/FI119972B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0463—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI931822A 1991-08-23 1993-04-22 Infektioiden kuvastaminen FI119972B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB919118183A GB9118183D0 (en) 1991-08-23 1991-08-23 Imaging of infections
GB9118183 1991-08-23
PCT/GB1992/001548 WO1993003772A1 (en) 1991-08-23 1992-08-21 Imaging of infections
GB9201548 1992-08-21

Publications (3)

Publication Number Publication Date
FI931822A0 true FI931822A0 (fi) 1993-04-22
FI931822A FI931822A (fi) 1993-04-22
FI119972B FI119972B (fi) 2009-05-29

Family

ID=10700409

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931822A FI119972B (fi) 1991-08-23 1993-04-22 Infektioiden kuvastaminen

Country Status (14)

Country Link
US (1) US5425935A (fi)
EP (1) EP0554434B1 (fi)
JP (2) JP3650107B2 (fi)
KR (1) KR100242177B1 (fi)
AT (1) ATE206934T1 (fi)
AU (1) AU665568B2 (fi)
CA (1) CA2094494C (fi)
DE (1) DE69232134T2 (fi)
DK (1) DK0554434T3 (fi)
ES (1) ES2161694T3 (fi)
FI (1) FI119972B (fi)
GB (2) GB9118183D0 (fi)
NO (1) NO310499B1 (fi)
WO (1) WO1993003772A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222574B1 (hu) * 1993-03-31 2003-08-28 Mallinckrodt Medical Inc. Redukálószerként foszfinokat tartalmazó radioaktív gyógyászati készítmények és az ezeket tartalmazó készletek
US5804158A (en) * 1995-05-31 1998-09-08 Resolution Pharmaceuticals Inc. Sequestered imaging agents
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US6017511A (en) * 1997-05-30 2000-01-25 Resolution Pharmaceuticals Inc. Glycopeptide-chelator conjugates
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
KR20020064057A (ko) * 2001-01-31 2002-08-07 최원식 세균감염 핵의학 영상진단 키트의 제조방법 및 그 키트준비물, 그 키트를 이용한 세균감염 진단방법
DE10139965B4 (de) * 2001-08-14 2005-12-29 Biotest Ag Gammasterilisierbares Kulturmedium zum Nachweis von Hefen und Pilzen
US20060110787A1 (en) * 2004-11-19 2006-05-25 The Board Trustees Of The University Of Arkansas Use of fluorine-18-labeled fluoroquinolone antibiotics for diagnosing and monitoring bacterial infection
KR100806368B1 (ko) * 2006-03-10 2008-02-27 최원식 결핵 핵의학 영상 조영제로서의 방사성 핵종-피라진아미드조성물 및 그 키트
EP2056709A4 (en) * 2006-08-11 2013-05-01 Univ New Jersey Med DOUBLE-SENSITIZER WITH LUMINESCENCE COMPOUNDS, CONJUGATES AND USE
CN101665520B (zh) * 2009-10-16 2011-12-07 北京师范大学 一种99TcmN(NFXDTC)2配合物及其制备方法和应用
WO2011088193A2 (en) 2010-01-13 2011-07-21 University Of Medicine And Dentistry Of New Jersey Fluorophore chelated lanthanide luminiscent probes with improved quantum efficiency
RU2506954C1 (ru) * 2012-12-05 2014-02-20 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Национальный исследовательский Томский политехнический университет" СПОСОБ ПРИГОТОВЛЕНИЯ РЕАГЕНТА ДЛЯ ПОЛУЧЕНИЯ МЕЧЕНОГО ТЕХНЕЦИЕМ-99м НОРФЛОКСАЦИНА
DE102017218119A1 (de) * 2017-10-11 2019-04-11 Christian-Albrechts-Universität Zu Kiel In der Umwelt abbaubare Chinolon-Antibiotika mit Hemiaminal-Struktureinheit

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873680A (en) * 1972-08-30 1975-03-25 Minnesota Mining & Mfg Mercaptan and thioketal complexes of technetium 99M for diagnostic scanning
FR2281134A1 (fr) * 1974-08-06 1976-03-05 Commissariat Energie Atomique Procede de marquage au 99m technetium
USRE31463E (en) * 1975-03-03 1983-12-13 Research Corporation Radiopharmaceutical chelates and method of external imaging
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
HU198709B (en) * 1987-04-08 1989-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
US5245026A (en) * 1987-09-24 1993-09-14 Abbott Laboratories Metal containing 8-hydroxyquinoline chelating agents
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
DE69019859T2 (de) * 1989-03-30 1995-10-05 Wakunaga Seiyaku Kk Chinolon-Derivate und deren Salze, Verfahren zu deren Herstellung und diese enthaltende antibakterielle Wirkstoffe.
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
JP3153549B2 (ja) * 1989-12-29 2001-04-09 アボツト・ラボラトリーズ キノロンカルボン酸―金属イオン―酸錯体
FR2672597B1 (fr) * 1991-02-07 1995-05-19 Roussel Uclaf Nouveaux derives n-substitues de la quinoleine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US5093105A (en) * 1991-04-09 1992-03-03 Merck Frosst Canada, Inc. Radiopharmaceutical bacteriostats

Also Published As

Publication number Publication date
GB2262937A (en) 1993-07-07
EP0554434B1 (en) 2001-10-17
AU2470192A (en) 1993-03-16
US5425935A (en) 1995-06-20
GB9118183D0 (en) 1991-10-09
NO310499B1 (no) 2001-07-16
JPH06505995A (ja) 1994-07-07
CA2094494C (en) 2005-07-12
KR100242177B1 (ko) 2000-03-02
AU665568B2 (en) 1996-01-11
CA2094494A1 (en) 1993-02-24
ES2161694T3 (es) 2001-12-16
NO931477L (no) 1993-04-22
GB2262937B (en) 1995-07-12
JP2004132990A (ja) 2004-04-30
DE69232134D1 (de) 2001-11-22
WO1993003772A1 (en) 1993-03-04
EP0554434A1 (en) 1993-08-11
GB9217828D0 (en) 1992-10-07
DE69232134T2 (de) 2002-03-21
JP3650107B2 (ja) 2005-05-18
NO931477D0 (no) 1993-04-22
FI931822A (fi) 1993-04-22
KR930701965A (ko) 1993-09-08
DK0554434T3 (da) 2001-11-12
FI119972B (fi) 2009-05-29
ATE206934T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
FI931822A0 (fi) Foerestaellning av infektioner
MX9101999A (es) Agentes complejantes e inmunoreactivos radioactivos de objetivo, utiles en composiciones y metodos de formacion de imagen terapeuticos y de diagnostico.
DE69226197D1 (de) Hämoglobine als arzneimittelabgabesystem
HUT73417A (en) Enniatines and enniatine derivatives used to control endoparasites
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
SE8404283L (sv) Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar
NO914375L (no) 7-acyl-3-(substituerte carbamoyloxy)cefem-forbindelser ogfremgangsmaate for fremstilling av disse
FI860426A (fi) Primycinkomponenter samt foerfarande foer avskiljning av antibiotkomplex.
ID16479A (id) Senyawa-senyawa pengobatan
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
ATE27279T1 (de) (1,2-diphenyl-ethylendiamin)-platin(ii)komplexverbindungen.
DE69313106D1 (de) Substituierte 1,1,2,-triphenylbutene und ihre verwendung zur behandlung und diagnose von krebs
ES2050449T3 (es) Dispositivo de centelleo utilizable para medir la atenuacion por tomografia de transmision.
SE8007290L (sv) Tomografiavsokningsanordning
ES469206A1 (es) Un procedimiento para preparar acido 7 b-haloarilmalonamido-7-metoxi-3-tiometil heterociclico-1-destia-1-oxa-3-cefem-4- carboxilico
NO983371L (no) Kontrastmedier
GR3019565T3 (en) Substituted 3-thia- or 3-oxa-alkyl flavones, process for their preparation, their application and drugs based on these compounds as well as intermediates
Meckstroth et al. Techniques in pancreas imaging
BG51067A1 (en) Radioprotective composition
SE8801467L (sv) Sett och komposition for avlegsnande av radioaktiva cesiumisotoper i biologiska system
Trapeznikov et al. The method for radioisotope diagnostics of skin malignant tumours
UA16689A1 (uk) Комбіhоваhий детектор для реhтгеhівської обчислювальhої томографії
IT1241449B (it) Preparato antiinfiammatorio ad uso oftalmico.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119972

Country of ref document: FI

MM Patent lapsed